계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Kuur Therapeutics
company
About
Kuur Therapeutics is committed to transforming the lives of patients with cancer & is leading the development cell therapies.
- 51 - 100
Highlights
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- £17M
- Industries
- Biotechnology,Health Care,Medical
- Founded date
- Jan 1, 2005
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Kuur Therapeutics is committed to transforming the lives of patients with cancer and is leading the development of off-the-shelf engineered CAR-NKT cell therapies.Our approach combines the highly differentiated, natural biology of a specific subset of cytotoxic T cells, called natural killer T cells (NKT cells) and innovative CAR construct engineering. In combination, this delivers a very compelling and unique platform, that we believe has the potential to produce many future therapies targeting both hematological and solid tumors.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
£67M
Kuur Therapeutics has raised a total of
£67M
in funding over 2 rounds. Their latest funding was raised on
Nov 25, 2014 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 25, 2014 | Series B | £50M | 1 | — | — | Detail |
| Jul 23, 2012 | Series Unknown | £17M | 1 | — | — | Detail |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
